ダウンロード数 : ?
言語
英語
著者
Li Jinpeng Department of Diabetology and Endocrinology
Liu Haijie Department of Diabetology and Endocrinology
Takagi, Susumu Department of Diabetology and Endocrinology
Nitta, Kyoko Department of Diabetology and Endocrinology
Kitada, Munehiro 1Department of Diabetology and Endocrinology and 2Division of Anticipatory Molecular Food Science and Technology, Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
Srivastava Swayam Prakash Department of Diabetology and Endocrinology / Nephrology Section, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Takagaki, Yuta Department of Diabetology and Endocrinology
Koya, Daisuke 1Department of Diabetology and Endocrinology and 2Division of Anticipatory Molecular Food Science and Technology, Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
掲載誌名
JCI INSIGHT
5
6
ISSN(Online)
2379-3708
発行日
2020-03-26
DOI
PubMed ID
出版者
AMER SOC CLINICAL INVESTIGATION INC
資料タイプ
学術雑誌論文
部局
医学部
備考
Empagliflozin was provided by Boehringer Ingelheim through a material transfer agreement. This study was essentially supported by a 2016 grant from the Japan Diabetes Foundation. This work was partially supported by the Japan Society for the Promotion of Science to KK (grants 23790381 and 23790381) and DK (grants 25282028 and 25670414). This work was partially supported by Grants for Collaborative Research awarded to DK (C2011-4 and C2012-1) and Grants for Promoted Research awarded to KK (S2015-3, S2016-3, and S20171) from Kanazawa Medical University. Boehringer Ingelheim, Mitsubishi-Tanabe Pharma, and Ono Pharmaceutical contributed to establishing the Division of Anticipatory Molecular Food Science and Technology.